Tech Company Financing Transactions

Allena Pharmaceuticals Funding Round

HBM Healthcare Investments, Bessemer Venture Partners and Frazier Healthcare Partners participated in a $25 million Series B venture round for Allena Pharmaceuticals. The round was recorded on 11/14/2014.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

1 Executive Park Dr. 202
Newton, MA 02462
USA

Phone

617-467-4577

Website

www.allenapharma.com

Email Address

[email protected]

Overview

Allena Pharmaceuticals (Nasdaq: ALNA) develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Louis Brenner

        

Chief Financial Officer

Edward Wholihan

        

Chief Medical Officer

Annamaria Kausz

        

Vice President

Geoffrey Swire

        

VP - Operations

Hugh Wight

        

VP - Regulatory Affairs

Stephen Yu

        

Browse more venture capital transactions:

Prev: 11/14/2014: Wannabiz venture capital transaction
Next: 11/14/2014: Metal Networks venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary